RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms . Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 49, n. 2, p. 359–366, 2013. DOI: 10.1590/S1984-82502013000200018. Disponível em: https://www.revistas.usp.br/bjps/article/view/68967.. Acesso em: 3 may. 2024.